Informationen:
Fehler:
ID
41202
Beschreibung
A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status; ODM derived from: https://clinicaltrials.gov/show/NCT01271010
Link
https://clinicaltrials.gov/show/NCT01271010
Stichworte
Versionen (1)
- 12.07.20 12.07.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
12. Juli 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Adult | Age
Item
adult patients, age 18-70 years
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
B-cell chronic lymphocytic leukemia Untreated
Item
diagnosis of previously untreated b-cell chronic lymphocytic leukemia
boolean
C0475774 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,2])
Age | Cumulative Illness Rating Scale for Geriatrics
Item
for patients, age 60-70 years: cumulative illness rating scale (cirs) comorbidity score </=6
boolean
C0001779 (UMLS CUI [1])
C4525403 (UMLS CUI [2])
C4525403 (UMLS CUI [2])
Binet Staging System | Disease Progression
Item
binet stage b, c or a with progression
boolean
C1511118 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
C0242656 (UMLS CUI [2])
Life Expectancy
Item
life expectancy >/=12 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Small Cell Lymphoma
Item
patients with small-cell lymphoma
boolean
C0024303 (UMLS CUI [1])
Autoimmune hemolytic anemia
Item
patients with auto-immune hemolytic anemia
boolean
C0002880 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma
Item
concomitant malignant disease during enrollment, except basal cell carcinoma of the skin
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
Chemotherapy Comorbidity
Item
chemotherapy for concomitant disease give within 12 months prior to study enrollment
boolean
C0392920 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])
Richter's syndrome
Item
patients with richter's syndrome
boolean
C0349631 (UMLS CUI [1])